Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- história de evento incitante (por exemplo, piercing, cirurgia, vacinação)
- crescimento lento/ausência de regressão espontânea
- cicatriz elevada, eritematosa, lisa e brilhante com borda saliente
Outros fatores diagnósticos
- prurido ou dor
Fatores de risco
- história anterior de queloide
- tensão local na pele
- inflamação/infecção folicular
- história familiar de queloide e fatores genéticos
- tipos de pele escura
- Estado hormonal
- doenças sistêmicas (por exemplo, hipertensão, eczema atópico, doença de Castleman)
- fatores de estilo de vida
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- diagnóstico clínico
Investigações a serem consideradas
- biópsia de pele
Algoritmo de tratamento
queloide pequeno/único
queloides grandes/volumosos/múltiplos
Colaboradores
Autores
Ioannis Goutos, FRCSEd(Plast)
Consultant Plastic Surgeon
Director of Academic Plastic Surgery Programmes
Queen Mary University of London
London
UK
Declarações
IG is an author of a number of references cited in this topic.
Richard Shaffer, MRCP, FRCR
Consultant Clinical Oncologist
GenesisCare
Cromwell Hospital
London
UK
Declarações
RS wrote the radiotherapy section of this topic. At the time of writing, he had received funds as a consultant as clinical lead for GenesisCare for skin and benign radiotherapy and as medical director for XStrahl, which designs and manufactures radiotherapy machines that can be used to treat keloid scars. RS has spoken at educational events on radiotherapy for keloid scarring and other benign and malignant conditions and has a working relationship with plastic surgeons who refer patients for radiotherapy for keloid scarring.Since contributing to the topic, RS has declared that he treats patients with radiotherapy for keloid scars in the private sector for GenesisCare and has received consulting fees from GenesisCare. He is also reimbursed for being a medical director and a shareholder and board member of Xstrahl Limited. He is board member and president of International Organisation for Radiotherapy for Benign Conditions (a community interest company), and has given webinars on the topic of radiotherapy for keloid scars for them. He is director and chief medical officer of Theralife, a company formed to treat patients with radiotherapy for non-cancer conditions. He works clinically with Ioannis Goutos for the benefit of patients with keloid scars. RS will not make further contributions to this topic.
Agradecimentos
Mr Ioannis Goutos and Dr Richard Shaffer would like to gratefully acknowledge Professor Andrew Burd, and Dr Lin Huang, previous contributors to this topic.
Declarações
AB and LH are authors of a number of references cited in this topic.
Revisores
Edward E. Tredget, MD, MSc, FRCSC
Director
Firefighters' Burn Treatment Unit and Plastic Surgery Wound Healing Research Laboratory
Professor
Department of Surgery
University of Alberta
Edmonton
Alberta
Canada
Declarações
EET declares that he has no competing interests.
Boni E. Elewski, MD
Professor and Chair of Dermatology
University of Alabama
Birmingham
AL
Declarações
BEE declares that she has no competing interests for this topic.
Diagnósticos diferenciais
- Cicatriz hipertrófica
- Dermatofibrossarcoma protuberante
- Dermatofibroma
Mais Diagnósticos diferenciaisDiretrizes
- Recommendations for using radiotherapy for benign disease in the UK: keloid scarring
- S2k guidelines for the therapy of pathological scars (hypertrophic scars and keloids)
Mais Diretrizes
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal